Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nutritional counselling for head and neck cancer patients treated with (chemo)radiation therapy: why, how, when, and what?
Santo B, Bertini N, Cattaneo CG, De Matteis S, De Franco P, Grassi R, Iorio GC, Longo S, Boldrini L, Piras A, Desideri I, De Felice F, Salvestrini V. Santo B, et al. Among authors: bertini n. Front Oncol. 2024 Jan 9;13:1240913. doi: 10.3389/fonc.2023.1240913. eCollection 2023. Front Oncol. 2024. PMID: 38264757 Free PMC article. No abstract available.
Choline PET/CT in recurrent prostate cancer.
Detti B, Carnevale MG, Lucidi S, Burchini L, Caini S, Orsatti C, Bertini N, Roghi M, di Cataldo V, Fondelli S, Ingrosso G, Francolini G, Scartoni D, Sardaro A, Pisani A, Scoccianti S, Aristei C, Livi L. Detti B, et al. Among authors: bertini n. Front Oncol. 2023 Mar 21;13:1079808. doi: 10.3389/fonc.2023.1079808. eCollection 2023. Front Oncol. 2023. PMID: 37025599 Free PMC article.
Pattern of recurrence after stereotactic body radiotherapy for para-aortic oligo-recurrent prostate cancer, a multicentric analysis.
Francolini G, Garlatti P, Di Cataldo V, Triggiani L, Simoni N, Detti B, Lorenzetti V, Colombo F, Morelli V, Ganovelli M, Caprara L, Orsatti C, Burchini L, Frosini G, Bertini N, Loi M, Simontacchi G, Greto D, Desideri I, Meattini I, Livi L. Francolini G, et al. Among authors: bertini n. Radiol Med. 2023 Nov;128(11):1423-1428. doi: 10.1007/s11547-023-01701-x. Epub 2023 Aug 19. Radiol Med. 2023. PMID: 37597125
Stereotactic reirradiation with CyberknifeR for locally recurrent prostate cancer, long-term toxicity and clinical outcomes from a monocentric cohort.
Francolini G, Carnevale MG, Di Cataldo V, Loi M, Detti B, Orsatti C, Caprara L, Bertini N, Lorenzetti V, Olmetto E, Becherini C, Visani L, Salvestrini V, Simontacchi G, Greto D, Bonomo P, Doro R, Masi L, Desideri I, Meattini I, Serni S, Livi L. Francolini G, et al. Among authors: bertini n. Radiol Med. 2023 Dec;128(12):1580-1588. doi: 10.1007/s11547-023-01721-7. Epub 2023 Sep 20. Radiol Med. 2023. PMID: 37728816
Impact of fosaprepitant in the prevention of nausea and emesis in head and neck cancer patients undergoing cisplatin-based chemoradiation: a pilot prospective study and a review of literature.
Becherini C, Salvestrini V, Desideri I, Vagnoni G, Bonaparte I, Bertini N, Mattioli C, Angelini L, Visani L, Scotti V, Livi L, Caini S, Bonomo P. Becherini C, et al. Among authors: bertini n. Radiol Med. 2024 Mar;129(3):457-466. doi: 10.1007/s11547-024-01757-3. Epub 2024 Feb 14. Radiol Med. 2024. PMID: 38351333 Free PMC article. Review.
Image-guided moderately hypofractionated radiotherapy for localized prostate cancer: a multicentric retrospective study (IPOPROMISE).
Ingrosso G, Ponti E, Francolini G, Caini S, Fondelli S, Santini R, Valeriani M, Rago L, Duroni G, Bruni A, Augurio A, Tramacere F, Trippa F, Russo D, Bottero M, Tamburo M, Parisi S, Borghesi S, Lancia A, Gomellini S, Scoccianti S, Stefanacci M, Vullo G, Statuto T, Miranda G, Santo B, Di Marzo A, Bellavita R, Vinciguerra A, Livi L, Aristei C, Bertini N, Orsatti C, Detti B. Ingrosso G, et al. Among authors: bertini n. Radiol Med. 2024 Apr;129(4):643-652. doi: 10.1007/s11547-024-01782-2. Epub 2024 Feb 19. Radiol Med. 2024. PMID: 38369638 Free PMC article.
Anatomical assessment of local recurrence site in breast cancer patients after breast reconstruction and post-mastectomy radiotherapy: implications for radiation volumes and techniques.
Salvestrini V, Valzano M, Meattini I, Becherini C, Visani L, Francolini G, Morelli I, Bertini N, Orzalesi L, Bernini M, Bianchi S, Simontacchi G, Livi L, Desideri I. Salvestrini V, et al. Among authors: bertini n. Radiol Med. 2024 Apr 11. doi: 10.1007/s11547-024-01812-z. Online ahead of print. Radiol Med. 2024. PMID: 38602657
PERSIAN trial (NCT05717660): an ongoing randomized trial testing androgen deprivation therapy, apalutamide and stereotactic body radiotherapy. An alternative "triplet" for oligometastatic hormone sensitive prostate cancer patients.
Francolini G, Porreca A, Facchini G, Santini D, Bruni A, Simoni N, Trovò M, Osti MF, Fornarini G, Sisani M, Di Cataldo V, Detti B, Garlatti P, Bertini N, Serni S, Minervini A, Livi L. Francolini G, et al. Among authors: bertini n. Med Oncol. 2023 Dec 29;41(1):39. doi: 10.1007/s12032-023-02268-3. Med Oncol. 2023. PMID: 38157111 Clinical Trial.
Modulation of tumor-associated macrophage activity with radiation therapy: a systematic review.
Becherini C, Lancia A, Detti B, Lucidi S, Scartoni D, Ingrosso G, Carnevale MG, Roghi M, Bertini N, Orsatti C, Mangoni M, Francolini G, Marani S, Giacomelli I, Loi M, Pergolizzi S, Bonzano E, Aristei C, Livi L. Becherini C, et al. Among authors: bertini n. Strahlenther Onkol. 2023 Dec;199(12):1173-1190. doi: 10.1007/s00066-023-02097-3. Epub 2023 Jun 22. Strahlenther Onkol. 2023. PMID: 37347290 Free PMC article. Review.
Adverse events related to drug-drug interactions in COVID-19 patients. A persistent concern in the post-pandemic era: a systematic review.
Conti V, Bertini N, Ricciardi R, Stefanelli B, De Bellis E, Sellitto C, Cascella M, Sabbatino F, Corbi G, Pagliano P, Filippelli A. Conti V, et al. Among authors: bertini n. Expert Opin Drug Metab Toxicol. 2024 Apr;20(4):275-292. doi: 10.1080/17425255.2024.2339397. Epub 2024 Apr 5. Expert Opin Drug Metab Toxicol. 2024. PMID: 38568077
28 results